Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

You are here: Industry Insights > Anika

News List

Anika’s combo arthritis drug Cingal flunks phase 3 test fiercebiotech
June 25, 2018
It’s turned out to be a challenging 2018 for Anika Therapeutics’ new CEO Joseph Darling—and a failed phase 3 trial for lead pipeline drug Cingal won’t make his job any easier.
Anika's osteoarthritis pain drug falls short at Phase 3 pharmafile
June 22, 2018
Anika Therapeutics has become the latest in a recent string of firms to suffer a failure in a late-stage trial,
FDA Green Lights Anika's Injectable HA-Based Bone Repair Treatment biospace
December 28, 2017
Anika Announces FDA 510(k) Clearance for Its Injectable HA-Based Bone Repair Treatment

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us: About PharmaSources; Terms of Service; Privacy Policy; Intellectual Property; Media Partners

Buy: Search Products; Post Sourcing Requests; Search Suppliers; CAS Search

Sell: Member Application; Advertising; Post Products; EZSourcing

Events: CPHI China; PMEC China; Conferences; Search Events

Help: FAQ; Contact Us; Feedback

Copyright 2006-2024 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182 沪公网安备31010402010101号
Links：
CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
Follow Us：
Pharma Sources Insight June 2024: Globalization on the Go

PharmaSources Customer Service